AstraZeneca’s breast cancer pill gets approval from the FDA
General Washington
Archived
•
September 5, 2026
•
AstraZeneca's breast cancer pill was authorized in an accelerated approval process, following an earlier vote against the medicine by the FDA's advisory panel.
Source: Seattle Times WA | https://www.seattletimes.com/feed/ - Read Original
Discussion (0)
Please log in to post a comment.
No comments yet. Be the first to share your thoughts!



